Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent
- PMID: 23197820
- PMCID: PMC3659701
- DOI: 10.5966/sctm.2012-0029
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent
Abstract
Induced pluripotent stem cells (iPSCs) have elicited excitement in both the scientific and ethics communities for their potential to advance basic and translational research. They have been hailed as an alternative to derivation from embryos that provides a virtually unlimited source of pluripotent stem cells for research and therapeutic applications. However, research with iPSCs is ethically complex, uniquely encompassing the concerns associated with genomics, immortalized cell lines, transplantation, human reproduction, and biobanking. Prospective donation of tissue specimens for iPSC research thus requires an approach to informed consent that is constructed for this context. Even in the nascent stages of this field, approaches to informed consent have been variable in ways that threaten the simultaneous goals of protecting donors and safeguarding future research and translation, and investigators are seeking guidance. We address this need by providing concrete recommendations for informed consent that balance the perspectives of a variety of stakeholders. Our work combines analysis of consent form language collected from investigators worldwide with a conceptual balancing of normative ethical concerns, policy precedents, and scientific realities. Our framework asks people to consent prospectively to a broad umbrella of foreseeable research, including future therapeutic applications, with recontact possible in limited circumstances. We argue that the long-term goals of regenerative medicine, interest in sharing iPSC lines, and uncertain landscape of future research all would be served by a framework of ongoing communication with donors. Our approach balances the goals of iPSC and regenerative medicine researchers with the interests of individual research participants.
Figures
Similar articles
-
Embryo-like features of induced pluripotent stem cells defy legal and ethical boundaries.Croat Med J. 2013 Dec;54(6):589-91. doi: 10.3325/cmj.2013.54.589. Croat Med J. 2013. PMID: 24382856 Free PMC article. No abstract available.
-
Patients' attitudes toward the donation of biological materials for the derivation of induced pluripotent stem cells.Cell Stem Cell. 2014 Jan 2;14(1):9-12. doi: 10.1016/j.stem.2013.12.006. Cell Stem Cell. 2014. PMID: 24388172 Free PMC article.
-
Participant understanding and recall of informed consent for induced pluripotent stem cell biobanking.Cell Tissue Bank. 2016 Sep;17(3):449-56. doi: 10.1007/s10561-016-9563-8. Epub 2016 Jun 14. Cell Tissue Bank. 2016. PMID: 27299783
-
Alternative sources of pluripotent stem cells: ethical and scientific issues revisited.Stem Cells Dev. 2010 Aug;19(8):1121-9. doi: 10.1089/scd.2009.0482. Stem Cells Dev. 2010. PMID: 20397928 Free PMC article. Review.
-
Return of results in translational iPS cell research: considerations for donor informed consent.Stem Cell Res Ther. 2013 Jan 21;4(1):6. doi: 10.1186/scrt154. Stem Cell Res Ther. 2013. PMID: 23336317 Free PMC article. Review.
Cited by
-
Advances and Challenges in Modeling Autosomal Dominant Polycystic Kidney Disease: A Focus on Kidney Organoids.Biomedicines. 2025 Feb 19;13(2):523. doi: 10.3390/biomedicines13020523. Biomedicines. 2025. PMID: 40002937 Free PMC article. Review.
-
The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.Stem Cells Transl Med. 2013 Oct;2(10):727-30. doi: 10.5966/sctm.2013-0099. Epub 2013 Aug 29. Stem Cells Transl Med. 2013. PMID: 23990574 Free PMC article.
-
cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.Stem Cell Reports. 2015 Oct 13;5(4):647-59. doi: 10.1016/j.stemcr.2015.08.015. Epub 2015 Sep 24. Stem Cell Reports. 2015. PMID: 26411904 Free PMC article.
-
Broad versus blanket consent for research with human biological samples.Hastings Cent Rep. 2013 Sep-Oct;43(5):3-4. doi: 10.1002/hast.200. Hastings Cent Rep. 2013. PMID: 24092578 Free PMC article. No abstract available.
-
Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs).Front Cell Dev Biol. 2021 Apr 28;9:627816. doi: 10.3389/fcell.2021.627816. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33996790 Free PMC article.
References
-
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. - PubMed
-
- Zhang X, De Los Angeles A, Zhang J. The art of human induced pluripotent stem cells: The past, the present and the future. Open Stem Cell J. 2010;2:2–7.
-
- Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. - PubMed
-
- Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources